The Kaplan–Meier analysis indicated RCC patients with a positive ATP1A1 expression had a significant longer survival time than those patients with a negative expression (P = 0.04 by the log-rank test, Fig. 3). Here, ATP1A1 is linked to renal cell carcinoma.